Sales rise 6.93% to Rs 7646.21 crore
Net profit of Aurobindo Pharma rose 7.95% to Rs 817.38 crore in the quarter ended September 2024 as against Rs 757.18 crore during the previous quarter ended September 2023. Sales rose 6.93% to Rs 7646.21 crore in the quarter ended September 2024 as against Rs 7150.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales7646.217150.71 7 OPM %20.4819.21 -PBDT1589.741493.14 6 PBT1207.461075.64 12 NP817.38757.18 8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content